- Home
- BCYC vs CLOV Comparison
BCYC vs CLOV Comparison
Compare BCYC & CLOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BCYC | CLOV |
|---|---|---|
| Founded | 2009 | 2014 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 516.8M | 1.3B |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | BCYC | CLOV |
|---|---|---|
| Price | $6.76 | $2.58 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 3 |
| Target Price | ★ $18.73 | $4.23 |
| AVG Volume (30 Days) | 281.9K | ★ 4.3M |
| Earning Date | 10-30-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $28,339,000.00 | ★ $1,773,564,000.00 |
| Revenue This Year | N/A | $41.68 |
| Revenue Next Year | N/A | $37.69 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 32.15 |
| 52 Week Low | $6.03 | $2.12 |
| 52 Week High | $17.04 | $4.87 |
Technical Indicators
Market Signals| Indicator | BCYC | CLOV |
|---|---|---|
| Relative Strength Index (RSI) | 44.72 | 46.66 |
| Support Level | $7.03 | $2.41 |
| Resistance Level | $7.50 | $2.74 |
| Average True Range (ATR) | 0.36 | 0.10 |
| MACD | -0.02 | 0.02 |
| Stochastic Oscillator | 10.87 | 33.35 |
Price Performance
Historical ComparisonAbout BCYC Bicycle Therapeutics plc
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.
About CLOV Clover Health Investments Corp.
Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.